Loading...

William Perry

Title(s)Professor In Residence, Psychiatry
SchoolHealth Sciences
Address200 W. Arbor Drive #8218
San Diego CA 92103
Phone619-543-2827
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Perry received his Ph.D. from the California School of Professional Psychology, San Diego in 1989. He completed his Internship and post-doctoral Fellowship at UCSD. He is a Fellow of the National Academy of Neuropsychology (NAN) as well as the Society for Personality Assessment and he serves as the Executive Director of NAN. His primary position in the Department of Psychiatry is as Vice Chair for Program Development and Operations and as the
    Co-Director, Division of Clinical Psychiatry. He also serves as the Chief Supervising psychologist at UCSD-Medical Center and engages in neuropsychological assessments.

    Research Interests

    Dr. Perry’s primary research program focuses on inhibitory and information processing deficits in neuropsychiatric conditions. He is the recipient of several grants to study acutely, un-medicated psychiatric patients using psychophysiological measures in order to characterize their inhibitory functions. Additionally, he is interested in conducting longitudinal studies, relating information processing deficits to thought disorder, neuropsychological and clinical measures. Although a majority of his publications are on patients with bipolar illness and schizophrenia, he has funded grants to study people with substance use disorders as well as people with viral diseases such as HIV and Hepatitis C.

    Clinical Focus

    As an active clinical Director, Dr. Perry serves as an Attending and is engaged in Psychiatry Consultation-Liaison work. He oversees consultation programs that have been developed with the UCSD Anesthesia Pain Management Group, Transplantation services and the Burn Service. He also serves as the Chief Supervising Psychologist at UCSD-Medical Center and as a member of Neuropsychological Associates is involved in outpatient neuropsychological and psychodiagnostic assessment.

    More on Dr. Perry's clinical information

    Collapse Research 
    Collapse Research Activities and Funding
    Cannabis use and the endocannabinoid system in bipolar disorder
    NIH/NIDA R01DA043535May 1, 2018 - Feb 28, 2023
    Role: Principal Investigator
    Endocannabinoid system and inhibition in bipolar disorder
    NIH/NIMH R21MH097112Sep 1, 2012 - Jun 30, 2014
    Role: Principal Investigator
    INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER
    NIH/NIMH R01MH071916Aug 25, 2004 - Jun 30, 2010
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disord. 2020 02; 22(1):46-58. Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, Perry W, Eyler LT. PMID: 31025493.
      View in: PubMed   Mentions:    Fields:    
    2. Amphetamine improves mouse and human attention in the 5-choice continuous performance test. Neuropharmacology. 2018 08; 138:87-96. MacQueen DA, Minassian A, Kenton JA, Geyer MA, Perry W, Brigman JL, Young JW. PMID: 29859849.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    3. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Pharmacol Biochem Behav. 2019 03; 178:42-50. Kwiatkowski MA, Hellemann G, Sugar CA, Cope ZA, Minassian A, Perry W, Geyer MA, Young JW. PMID: 29289701.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    4. The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania. Mol Neuropsychiatry. 2018 Feb; 3(3):151-156. Minassian A, Young JW, Geyer MA, Kelsoe JR, Perry W. PMID: 29594134.
      View in: PubMed   Mentions:
    5. Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults. J Int Neuropsychol Soc. 2018 03; 24(3):283-293. MacQueen DA, Minassian A, Henry BL, Geyer MA, Young JW, Perry W. PMID: 29032769.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. Neuropharmacology. 2017 Oct; 125:254-262. Cope ZA, Minassian A, Kreitner D, MacQueen DA, Milienne-Petiot M, Geyer MA, Perry W, Young JW. PMID: 28774856.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    7. Everyday functional ability in HIV and methamphetamine dependence. Drug Alcohol Depend. 2017 06 01; 175:60-66. Minassian A, Henry BL, Iudicello JE, Morgan EE, Letendre SL, Heaton RK, Perry W. PMID: 28399475.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury. J Neurotrauma. 2017 03 01; 34(5):1005-1016. Brandel MG, Hirshman BR, McCutcheon BA, Tringale K, Carroll K, Richtand NM, Perry W, Chen CC, Carter BS. PMID: 27573722.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Diagnosis and characterization of mania: Quantifying increased energy and activity in the human behavioral pattern monitor. Psychiatry Res. 2016 06 30; 240:278-283. Perry W, McIlwain M, Kloezeman K, Henry BL, Minassian A. PMID: 27138818.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology (Berl). 2016 Jan; 233(2):225-33. Minassian A, Young JW, Cope ZA, Henry BL, Geyer MA, Perry W. PMID: 26449721.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    11. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neurosci Biobehav Rev. 2015 Nov; 58:4-18. van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry BL, Young JW. PMID: 26297513.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    12. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2016 Jan; 30(1):251-8. Fuchs HF, Laughter V, Harnsberger CR, Broderick RC, Berducci M, DuCoin C, Langert J, Sandler BJ, Jacobsen GR, Perry W, Horgan S. PMID: 25847138.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. J Neurovirol. 2014 Dec; 20(6):561-70. Cattie JE, Letendre SL, Woods SP, Barakat F, Perry W, Cherner M, Umlauf A, Franklin D, Heaton RK, Hassanein T, Grant I. PMID: 25326107.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    14. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. Eur J Pharmacol. 2015 Apr 15; 753:114-26. van Enkhuizen J, Janowsky DS, Olivier B, Minassian A, Perry W, Young JW, Geyer MA. PMID: 25107282.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    15. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning. Psychiatry Res. 2014 Dec 15; 220(1-2):527-34. Morgan EE, Doyle KL, Minassian A, Henry BL, Perry W, Marcotte TD, Woods SP, Grant I. PMID: 25081313.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology. 2014 Dec; 39(13):3112-22. van Enkhuizen J, Henry BL, Minassian A, Perry W, Milienne-Petiot M, Higa KK, Geyer MA, Young JW. PMID: 25005251.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    17. Disentangling working memory processes during spatial span assessment: a modeling analysis of preferred eye movement strategies. J Clin Exp Neuropsychol. 2014; 36(2):186-204. Patt VM, Thomas ML, Minassian A, Geyer MA, Brown GG, Perry W. PMID: 24499103.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behav Pharmacol. 2014 Feb; 25(1):12-22. Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A. PMID: 24281153.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    19. Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor. J Affect Disord. 2013 Sep 25; 150(3):948-54. Henry BL, Minassian A, Patt VM, Hua J, Young JW, Geyer MA, Perry W. PMID: 23759280.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. Everyday functional ability across different phases of bipolar disorder. Psychiatry Res. 2013 Dec 30; 210(3):850-6. Henry BL, Minassian A, Perry W. PMID: 23643188.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc. 2013 Jul; 19(6):709-17. Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, Perry W. PMID: 23552464.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Outcomes and costs associated with robotic colectomy in the minimally invasive era. Dis Colon Rectum. 2013 Apr; 56(4):458-66. Tyler JA, Fox JP, Desai MM, Perry WB, Glasgow SC. PMID: 23478613.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    23. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res. 2013 Jan 01; 236(1):210-220. Henry BL, Geyer MA, Buell M, Perry W, Young JW, Minassian A. PMID: 22960458.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    24. Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk. Clin Neuropsychol. 2012; 26(4):654-74. Morgan EE, Woods SP, Rooney A, Perry W, Grant I, Letendre SL. PMID: 22533778.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    25. Assessment and usefulness of clinical scales for semiquantification of overt hepatic encephalopathy. Clin Liver Dis. 2012 Feb; 16(1):27-42. Sakamoto M, Perry W, Hilsabeck RC, Barakat F, Hassanein T. PMID: 22321463.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. PLoS One. 2011; 6(8):e24185. Minassian A, Henry BL, Young JW, Masten V, Geyer MA, Perry W. PMID: 21912623.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    27. Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology (Berl). 2011 Jun; 215(4):697-707. Henry BL, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W. PMID: 21279333.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    28. Effect of methamphetamine dependence on heart rate variability. Addict Biol. 2012 May; 17(3):648-58. Henry BL, Minassian A, Perry W. PMID: 21182570.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry. 2010 Oct 01; 68(7):678-80. Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A. PMID: 20615494.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    30. Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living. J Clin Exp Neuropsychol. 2010 Jul; 32(6):637-44. Posada C, Moore DJ, Woods SP, Vigil O, Ake C, Perry W, Hassanein TI, Letendre SL, Grant I. PMID: 20603743.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res. 2010 Jun 30; 178(1):84-91. Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA. PMID: 20471103.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    32. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev. 2010 Jul; 34(8):1296-306. Henry BL, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W. PMID: 20398694.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    33. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol Biochem Behav. 2010 Jul; 96(1):7-15. Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. PMID: 20363246.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    34. Role of Sleep Disturbance in Chronic Hepatitis C Infection. Curr Hepat Rep. 2010 Feb; 9(1):25-29. Carlson MD, Hilsabeck RC, Barakat F, Perry W. PMID: 20208985.
      View in: PubMed   Mentions:
    35. Effect of methamphetamine dependence on everyday functional ability. Addict Behav. 2010 Jun; 35(6):593-8. Henry BL, Minassian A, Perry W. PMID: 20167435.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    36. The quantitative assessment of motor activity in mania and schizophrenia. J Affect Disord. 2010 Jan; 120(1-3):200-6. Minassian A, Henry BL, Geyer MA, Paulus MP, Young JW, Perry W. PMID: 19435640.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    37. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl). 2010 Feb; 208(3):443-54. Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. PMID: 20020109.
      View in: PubMed   Mentions: 34     Fields:    Translation:Animals
    38. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry. 2009 Oct; 66(10):1072-80. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA. PMID: 19805697.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimals
    39. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res. 2010 Feb; 44(3):168-76. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. PMID: 19700172.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    40. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol. 2009 Jun; 104(6):1392-400. Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS, Caldwell S, McGuire B, Nevens F, Fontana R. PMID: 19455117.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    41. Beyond the numbers: expanding the boundaries of neuropsychology. Arch Clin Neuropsychol. 2009 Feb; 24(1):21-9. Perry W. PMID: 19395354.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res. 2009 Jan; 43(4):484-9. Feifel D, Minassian A, Perry W. PMID: 18674783.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    43. Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. J Clin Exp Neuropsychol. 2008 Oct; 30(7):805-15. Vigil O, Posada C, Woods SP, Atkinson JH, Heaton RK, Perry W, Hassanein TI, Grant I, Letendre SL. PMID: 18608687.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    44. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci. 2008 Feb; 53(2):529-38. Hassanein TI, Hilsabeck RC, Perry W. PMID: 17710551.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    45. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci. 2008 Feb; 53(2):307-21. Perry W, Hilsabeck RC, Hassanein TI. PMID: 17703362.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    46. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev. 2007; 31(6):882-96. Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. PMID: 17706782.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    47. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol. 2007 Feb; 22(2):175-86. Mooney S, Hasssanein TI, Hilsabeck RC, Ziegler EA, Carlson M, Maron LM, Perry W. PMID: 17280813.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    48. Adults with autism show increased sensitivity to outcomes at low error rates during decision-making. J Autism Dev Disord. 2007 Aug; 37(7):1279-88. Minassian A, Paulus M, Lincoln A, Perry W. PMID: 17080271.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr Res. 2007 Jan; 89(1-3):225-31. Minassian A, Feifel D, Perry W. PMID: 17005374.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    50. Sensorimotor gating deficits in adults with autism. Biol Psychiatry. 2007 Feb 15; 61(4):482-6. Perry W, Minassian A, Lopez B, Maron L, Lincoln A. PMID: 16460695.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    51. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS. 2005 Oct; 19 Suppl 3:S79-84. Perry W, Carlson MD, Barakat F, Hilsabeck RC, Schiehser DM, Mathews C, Hassanein TI. PMID: 16251832.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    52. Rapid oral loading of extended release divalproex in patients with acute mania. Gen Hosp Psychiatry. 2005 May-Jun; 27(3):218-21. Miller BP, Perry W, Moutier CY, Robinson SK, Feifel D. PMID: 15882770.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Visual scanning deficits in schizophrenia and their relationship to executive functioning impairment. Schizophr Res. 2005 Apr 01; 74(1):69-79. Minassian A, Granholm E, Verney S, Perry W. PMID: 15694756.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    54. A retrospective review of the neuropsychological test performance of physicians referred for medical infractions. Arch Clin Neuropsychol. 2005 Mar; 20(2):161-70. Perry W, Crean RD. PMID: 15708726.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Increased sensitivity to error during decision-making in bipolar disorder patients with acute mania. J Affect Disord. 2004 Oct 15; 82(2):203-8. Minassian A, Paulus MP, Perry W. PMID: 15488248.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2004 Sep 01; 56(5):333-9. Feifel D, Farber RH, Clementz BA, Perry W, Anllo-Vento L. PMID: 15336515.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    57. Prepulse inhibition in patients with non-psychotic major depressive disorder. J Affect Disord. 2004 Aug; 81(2):179-84. Perry W, Minassian A, Feifel D. PMID: 15306146.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    58. Pneumoretroperitoneum in two patients with Clostridium perfringens necrotizing pancreatitis. Am Surg. 2004 Mar; 70(3):268-71. Anderson CM, Kerby JD, Perry WB, Sorrells DL. PMID: 15055853.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    59. Pupillary dilation to simple vs. complex tasks and its relationship to thought disturbance in schizophrenia patients. Int J Psychophysiol. 2004 Mar; 52(1):53-62. Minassian A, Granholm E, Verney S, Perry W. PMID: 15003372.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    60. Let's call the whole thing off: a response to Dawes (2001). Psychol Assess. 2003 Dec; 15(4):582-5. Perry W. PMID: 14692852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. The category test perseveration, loss of set, and memory scales: three new scales and their relationship to executive functioning measures. Assessment. 2003 Sep; 10(3):213-21. Minassian A, Perry W, Carlson M, Pelham M, DeFilippis N. PMID: 14503644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. The use of the Ego Impairment Index across the schizophrenia spectrum. J Pers Assess. 2003 Feb; 80(1):50-7. Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. PMID: 12584067.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    63. Relationship of tinnitus questionnaires to depressive symptoms, quality of well-being, and internal focus. Int Tinnitus J. 2003; 9(2):97-103. Robinson SK, McQuaid JR, Viirre ES, Betzig LL, Miller DL, Bailey KA, Harris JP, Perry W. PMID: 15106282.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    64. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am J Psychiatry. 2002 Aug; 159(8):1375-81. Perry W, Feifel D, Minassian A, Bhattacharjie I, Braff DL. PMID: 12153831.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    65. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002 Feb; 35(2):440-6. Hilsabeck RC, Perry W, Hassanein TI. PMID: 11826421.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    66. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction. Schizophr Res. 2002 Jan 15; 53(3):199-207. Auslander LA, Perry W, Jeste DV. PMID: 11738533.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 2001 Sep 15; 50(6):418-24. Perry W, Minassian A, Feifel D, Braff DL. PMID: 11566158.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    68. Incremental validity of the Ego Impairment Index: a re-examination of Dawes (1999). Psychol Assess. 2001 Sep; 13(3):403-7. Perry W. PMID: 11556278.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001 Apr 15; 49(1-2):171-8. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. PMID: 11343875.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    70. Self-monitoring enhances Wisconsin Card Sorting Test performance in patients with schizophrenia: performance is improved by simply asking patients to verbalize their sorting strategy. J Int Neuropsychol Soc. 2001 Mar; 7(3):344-52. Perry W, Potterat EG, Braff DL. PMID: 11311035.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    71. Working memory in schizophrenia: transient "online" storage versus executive functioning. Schizophr Bull. 2001; 27(1):157-76. Perry W, Heaton RK, Potterat E, Roebuck T, Minassian A, Braff DL. PMID: 11215544.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    72. Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophr Res. 2000 Dec 15; 46(2-3):167-74. Perry W, Light GA, Davis H, Braff DL. PMID: 11120428.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    73. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000 Dec; 61(12):909-11. Feifel D, Moutier CY, Perry W. PMID: 11206594.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    74. The nonlinear, complex sequential organization of behavior in schizophrenic patients: neurocognitive strategies and clinical correlations. Biol Psychiatry. 1999 Sep 01; 46(5):662-70. Paulus MP, Perry W, Braff DL. PMID: 10472418.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology (Berl). 1999 Sep; 146(2):228-32. Swerdlow NR, Geyer MA, Hartman PL, Sprock J, Auerbach PP, Cadenhead K, Perry W, Braff DL. PMID: 10525760.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    76. Cognitive functions in schizotypal personality disorder. Schizophr Res. 1999 May 25; 37(2):123-32. Cadenhead KS, Perry W, Shafer K, Braff DL. PMID: 10374648.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    77. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry. 1999 Mar; 56(3):277-81. Perry W, Geyer MA, Braff DL. PMID: 10078506.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    78. The relationship between skin conductance hyporesponsivity and perseverations in schizophrenia patients. Biol Psychiatry. 1998 Sep 15; 44(6):459-65. Perry W, Felger T, Braff D. PMID: 9777177.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    79. A multimethod approach to assessing perseverations in schizophrenia patients. Schizophr Res. 1998 Sep 07; 33(1-2):69-77. Perry W, Braff DL. PMID: 9783346.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    80. Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res. 1997 Nov 07; 28(1):51-62. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL. PMID: 9428064.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    81. The relationship of information-processing deficits and clinical symptoms in schizotypal personality disorder. Biol Psychiatry. 1996 Nov 01; 40(9):853-8. Cadenhead KS, Perry W, Braff DL. PMID: 8896771.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    82. Latent inhibition in schizophrenia. Schizophr Res. 1996 May; 20(1-2):91-103. Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA. PMID: 8794497.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. Gender differences on thought disturbance measures among schizophrenic patients. Am J Psychiatry. 1995 Sep; 152(9):1298-301. Perry W, Moore D, Braff D. PMID: 7653684.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    84. Drug screening in "normal" controls. Biol Psychiatry. 1995 Jul 15; 38(2):123-4. Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. PMID: 7578645.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    85. Amphetamine on Rorschach measures in normal subjects. J Pers Assess. 1995 Jun; 64(3):456-65. Perry W, Sprock J, Schaible D, McDougall A, Minassian A, Jenkins M, Braff D. PMID: 7760256.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    86. The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc. 1995 Jan; 1(1):88-99. Paulsen JS, Heaton RK, Sadek JR, Perry W, Delis DC, Braff D, Kuck J, Zisook S, Jeste DV. PMID: 9375213.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    87. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 1994 Mar; 151(3):363-7. Perry W, Braff DL. PMID: 8109644.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    88. Weiner's Psychodiagnosis in schizophrenia: a classic revisited. J Pers Assess. 1994 Feb; 62(1):180-6. Perry W. PMID: 8138884.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. The Ego Impairment Index and schizophrenia: a validation study. J Pers Assess. 1992 Aug; 59(1):165-75. Perry W, Viglione D, Braff D. PMID: 1512674.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants. J Pers Assess. 1991 Jun; 56(3):487-501. Perry W, Viglione DJ. PMID: 1865307.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    William's Networks
    Concepts (304)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (43)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (57)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑